FNCH
Finch Therapeutics Group Inc
A biotech company that makes oral medicines built from beneficial gut microbes — known as microbiome therapeutics — to treat stubborn infections and inflammatory conditions. It was founded in 2014 by scientists who had earlier launched OpenBiome, a nonprofit stool bank, and its CEO turned to the field after a family member survived a serious C. diff infection that resisted standard treatment. The name honors Darwin's finches, a nod to how evolution shapes the tiny creatures living inside us.
CUSIP: 31773D101HealthcareUS1 holder
Total Value
$793.0K
Total Shares
2.02M
Net Share Change
+1.00M
Activity
1 buying
Investor
Value
Shares
Weight
Change
